C-KIT MUTATION DETECTION , PCR

c-Kit mutations are associated with shorter survival and higher relapse risk following standard AML therapy in AML Patients. It also confirms diagnosis of Systemic Mastocytosis where patients without the D816V pathogenic variation are sensitive to the tyrosine kinase inhibitor Imatinib mesylate (Imatinib).

  • Test Type:
  • Pre-test Information:
    No Special preparation required
  • Report Delivery:
    Sample by Wed / Sat 11 am; Report 9 days
  • Components:
    0